To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis" - A Randomized Open- Label Study
Phase of Trial: Phase IV
Latest Information Update: 24 Jan 2017
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 05 Feb 2016 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
- 29 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 10 Jun 2015 New trial record